Integer Announces Conference Call to Discuss Fourth Quarter and Full Year 2025 Results
Rhea-AI Summary
Integer (NYSE: ITGR) will webcast a conference call to discuss fourth quarter and full year results for the period ended Dec. 31, 2025, on Thursday, Feb. 19, 2026 at 8 a.m. CT / 9 a.m. ET.
The company will issue a news release with financial results prior to the call. Domestic dial-in: (800) 715-9871; international dial-in: (646) 307-1963; conference ID: 3120125. Webcast registration is available via the Integer investor site and an audio replay will be available for seven days by dialing (800) 770-2030 or (609) 800-9909 using the same conference ID. Live and archived replay will be on Integer's Investor Relations website.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
ITGR was up 2.17% while close peers were mixed: BRKR +3.57%, GKOS +2.35%, but TMDX -6.32%, HAE -0.88%, LIVN roughly flat. Moves do not indicate a unified sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 14 | Product showcase | Positive | +2.4% | Highlighted neuromodulation and AIMD innovations at NANS 2026 meeting. |
| Nov 18 | Investor conferences | Neutral | +1.0% | Planned participation in two December 2025 healthcare investor conferences. |
| Nov 04 | Share repurchase | Positive | +2.5% | Authorized <b>$200M</b> buyback funded primarily with cash and free cash flow. |
| Oct 24 | Leadership change | Neutral | -1.3% | New CEO Payman Khales assumed role, completing planned leadership transition. |
| Oct 23 | Q3 2025 earnings | Positive | -32.3% | Reported Q3 sales <b>$467.7M</b> and strong adjusted EPS but shares fell sharply. |
Recent clearly positive corporate actions (buyback) saw gains, while strong earnings previously coincided with a large selloff.
Over the last few months, Integer announced product innovation exposure at NANS (Jan 22–25, 2026), a new CEO effective Oct 24, 2025, a $200M share repurchase authorization on Nov 4, 2025, and strong Q3 2025 metrics with sales of $467.7M and adjusted EPS of $1.79. Despite positive fundamentals, that Q3 earnings release saw a -32.28% move, contrasting with the positive reaction to the buyback. Today’s scheduling release fits the pattern of routine earnings communication similar to prior quarter-call announcements.
Market Pulse Summary
This announcement schedules Integer’s Q4 and full-year 2025 earnings release and conference call for February 19, 2026, continuing a consistent pattern of pre-announcing quarterly calls with dial-in and webcast details. Investors may focus on how results compare to prior Q3 2025 figures, including sales of $467.7M and adjusted EPS of $1.79. Monitoring follow-up guidance and any strategic updates on the call will be important for assessing the company’s trajectory.
Key Terms
earnings call financial
webcast technical
AI-generated analysis. Not financial advice.
PLANO, Texas, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the fourth quarter and year ended Dec. 31, 2025, on Thursday, Feb. 19, 2026, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information may also be discussed during this call. The company will issue a news release announcing financial results for the fourth quarter and full year on Feb. 19 prior to the conference call.
Conference call details:
- Date: Thursday, Feb. 19, 2026
- Time: 8 a.m. CT / 9 a.m. ET
- Domestic dial-in number: (800) 715-9871
- International dial-in number: (646) 307-1963
- Conference ID: 3120125
- Webcast Registration: ITGR Q4 2025 Earnings Call
An audio replay will be available for seven days and can be accessed by dialing (800) 770-2030 or (609) 800-9909 and using Conference ID 3120125. The conference call will also be available live or via archived replay on the Investor Relations section of the Integer website at: investor.integer.net.
From time to time, Integer posts information that may be of interest to investors on its website. To automatically receive Integer financial news by email, please visit investor.integer.net and subscribe to email alerts.
Learn more about Integer at www.integer.net.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.
| Investor Relations: Kristen Stewart kristen.stewart@integer.net 551.337.3973 | Media Relations: Misty Tippen misty.tippen@integer.net 469.536.6702 |